[HTML][HTML] The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention

S Domínguez-Zorita, JM Cuezva - Cancers, 2023 - mdpi.com
… whereas OXPHOS prevails in differentiated cells [180,181]. Interestingly, IF1 also plays a
relevant role in metabolic reprogramming during differentiation of human mesenchymal stem …

Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative …

F Yang, Wendusubilige, J Kong, Y Zong, M Wang… - EPMA Journal, 2023 - Springer
… patients who were sensitive to antioxidant therapy to conduct differential gene functional
enrichment analysis and predict potential therapeutic drugs. Diagnostic markers between …

Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape

X Xie, J Lee, T Iwase, M Kai… - … Opinion on Therapeutic …, 2022 - Taylor & Francis
… TNBC treatment discovered in early translational studies. We focus on cancer cell membrane
molecules, hyperactive intracellular signaling pathways, and the tumor microenvironment (…

Diagnostics and Therapeutic Potential of miR-205 and miR-34a in Ovarian Cancer Management: A miRNA-Target-Based Analysis

V Kumar, A Pandey, A Arora, P Gautam… - DNA and Cell …, 2023 - liebertpub.com
… can only be provided when the incidence of the disease is diagnosed in the early stages, …
disease progression since they are involved in essential processes such as cell differentiation, …

ERα inhibits mesenchymal and amoeboidal movement of liver cancer cell via Gα12

J Yun, YS Kim, MJ Heo, MJ Kim… - … Journal of Cancer, 2022 - Wiley Online Library
… , and consequent better survival rates observed in females, supporting the idea that modulating
the ERα-Gα12 pathway may be utilized for sex differential approaches in HCC treatment. …

[HTML][HTML] … Bioinformatics Analysis on the Role of Long Non-Coding RNAs as Drivers and Gatekeepers of Androgen-Independent Prostate Cancer Using LNCaP and PC …

M Mbeje, J Kandhavelu, C Penny… - Current Issues in …, 2023 - mdpi.com
… functions such as cell differentiation, development, and the cell … cancers and aid their
resistance to cancer therapies [25]. Hsa-miR-… The cancer progression targets are shown in green …

[HTML][HTML] A plasma proteomic approach in patients with heart failure after acute myocardial infarction: insights into the pathogenesis and progression of the disease

Y Liu, D Huang, Z Li, LF Zhou, T Cen, B Wei… - Frontiers in …, 2023 - frontiersin.org
… Aims: The pathogenesis of disease progression targets for … Guidelines for the diagnosis and
treatment of acute and chronic … By using differential analysis, when P < 0.05, the differential

Natural Sourced inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated signaling pathways as potential anticancer agents

S Nandi, R Dey, A Samadder, A Saxena… - Current Medicinal …, 2022 - ingentaconnect.com
… carcinoma and gastrointestinal stromal tumors [57]. The Lenvatinib [58] and vandetanib
are used for the treatment of progressive and locally advanced differentiated thyroid cancer [59]. …

Emergence of circulating MicroRNAs in breast cancer as diagnostic and therapeutic efficacy biomarkers

V Aggarwal, K Priyanka, HS Tuli - Molecular diagnosis & therapy, 2020 - Springer
… In addition, they are also important in cell development and differentiation, tumor proliferation,
and apoptosis. More than 2000 miRNAs have been found to be associated with numerous …

[PDF][PDF] PROTAC-An Outstanding Promising Technology in Drug Development and Cancer Therapy: a Review

P Roy, M Koley, A Bera, S Set, R Goswami - researchgate.net
… Its function in B cells is to promote development, differentiation, and signal transduction. …
preclinical treatment targets; and validate previously discovered disease progression targets. (…